DK1500390T3 - Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1500390T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; dosage form; solid dosage; preparation; desmopressin
Prior art date: 2003-07-25

Application number

DK03016945T

Other languages

English (en)

Inventor

Hakan Lomryd

Helena Nicklasson

Lars-Erik Olsson

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-25

Filing date

2003-07-25

Publication date

2005-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1500390(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-07-25 Application filed by Ferring Bv filed Critical Ferring Bv

2005-09-19 Application granted granted Critical

2005-09-19 Publication of DK1500390T3 publication Critical patent/DK1500390T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK03016945T 2003-07-25 2003-07-25 Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf DK1500390T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/626,857 US7022340B2 (en)	2003-07-25	2003-07-25	Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP03016945A EP1500390B1 (en)	2003-07-25	2003-07-25	Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof

Publications (1)

Publication Number	Publication Date
DK1500390T3 true DK1500390T3 (da)	2005-09-19

Family

ID=34117527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03016945T DK1500390T3 (da)	2003-07-25	2003-07-25	Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf

Country Status (21)

Country	Link
US (1)	US7022340B2 (da)
EP (1)	EP1500390B1 (da)
JP (1)	JP4430673B2 (da)
KR (1)	KR20050104331A (da)
AT (1)	ATE301990T1 (da)
AU (1)	AU2004260625B2 (da)
BR (1)	BRPI0412905A (da)
CA (1)	CA2490335C (da)
DE (1)	DE60301351T2 (da)
DK (1)	DK1500390T3 (da)
ES (1)	ES2243840T3 (da)
IL (1)	IL187591A0 (da)
MX (1)	MXPA06000903A (da)
NO (1)	NO327328B1 (da)
NZ (1)	NZ544104A (da)
PL (1)	PL379704A1 (da)
PT (1)	PT1500390E (da)
RU (1)	RU2303439C2 (da)
SI (1)	SI1500390T1 (da)
TW (1)	TWI268782B (da)
WO (1)	WO2005011640A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0210397D0 (en) *	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
US7094545B2 (en) *	2003-04-30	2006-08-22	Ferring Bv	Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) *	2003-07-25	2010-06-09	凡林有限公司	固体剂型药物组合物及其制造方法
ATE324869T1 (de) *	2003-11-13	2006-06-15	Ferring Bv	Blisterverpackung und feste dosierungsform enthaltend desmopressin
CA2490601C (en) *	2003-12-29	2006-05-02	Ferring B.V.	Method for preparing solid dosage form of desmopressin
US7018653B2 (en) *	2003-12-29	2006-03-28	Ferring B.V.	Method for preparing solid dosage form of desmopressin
SE528446C2 (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es)	2007-08-06	2010-02-12	Gp Pharm S.A.	Composicion farmaceutica oral de desmopresina.
CN101801452B (zh)	2007-08-06	2014-10-22	阿勒根公司	用于去氨加压素药物给送的设备
EP2249813A1 (en) *	2008-03-11	2010-11-17	Mallinckrodt Inc.	Use of magnesium stearate dihydrate for lubrication of solid pharmaceutical compositions
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
SI3225249T1 (sl) *	2008-05-21	2019-02-28	Ferring B.V.	Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija
KR20110089265A (ko) *	2008-09-30	2011-08-05	미쓰이 가가쿠 가부시키가이샤	섬유 강화 수지 조성물 및 그의 성형체
JP2022130075A (ja) *	2021-02-25	2022-09-06	フロイント産業株式会社	顆粒及びその製造方法、並びに錠剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8306367L (sv) *	1983-11-18	1985-05-19	Ferring Ab	Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) *	1985-08-02	1987-06-23	Stauffer Chemical Company	Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) *	1986-03-24	1989-04-11	Em Diagnostic Systems, Inc.	Method of preparing particles suitable for tabletting into diagnostic reagents
JP3118255B2 (ja) *	1991-01-30	2000-12-18	ザウエルカムファウンデーションリミテッド	水分散性錠剤
US5482931A (en)	1993-06-29	1996-01-09	Ferring Ab	Stabilized pharmaceutical peptide compositions
AU1677095A (en)	1994-01-11	1995-08-01	Alkermes Controlled Therapeutics, Inc.	Oral dosage form of desmopressin (ddavp)
SE9400918L (sv)	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
US5849322A (en)	1995-10-23	1998-12-15	Theratech, Inc.	Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en)	1995-12-23	1996-02-28	Knoll Ag	Therapeutic agents
DE19602757A1 (de) *	1996-01-26	1997-07-31	Boehringer Mannheim Gmbh	Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
SE9604341D0 (sv) *	1996-11-26	1996-11-26	Ferring Bv	Hepta-peptide oxytocin analogue
WO2000009423A1 (es)	1998-08-11	2000-02-24	Jaime Marti Sala	Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de)	2000-02-16	2002-05-27	Gebro Pharma Gmbh	Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
PE20011227A1 (es) *	2000-04-17	2002-01-07	Chiesi Farma Spa	Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
AU782841B2 (en)	2000-04-17	2005-09-01	Vectura Limited	Improvements in or relating to formulations for use in inhaler devices
GB0009469D0 (en) *	2000-04-17	2000-06-07	Vectura Ltd	Improvements in or relating to formalities for use in inhaler devices
GB0010709D0 (en)	2000-05-03	2000-06-28	Vectura Ltd	Powders for use a in dry powder inhaler
ATE378039T1 (de)	2000-06-27	2007-11-15	Vectura Ltd	Herstellungsverfahren für partikel zur verwendung in einer arzneizusammensetzung
ES2268020T3 (es) *	2001-05-10	2007-03-16	Astellas Pharma Inc.	Comprimidos de disgregacion rapida de la cavidad oral y proceso para producir los mismos.
MXPA04003540A (es)	2001-10-15	2004-07-22	R Hm Gmbh & Co Kg	Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.
NZ535861A (en)	2002-05-07	2006-11-30	Ferring Bv	Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
US7094545B2 (en) *	2003-04-30	2006-08-22	Ferring Bv	Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE60300414T2 (de) *	2003-04-30	2006-05-11	Ferring B.V.	Feste Dosierungsform mit Desmopressin

2003
- 2003-07-25 DE DE60301351T patent/DE60301351T2/de not_active Expired - Lifetime
- 2003-07-25 SI SI200330100T patent/SI1500390T1/sl unknown
- 2003-07-25 AT AT03016945T patent/ATE301990T1/de active
- 2003-07-25 US US10/626,857 patent/US7022340B2/en not_active Expired - Fee Related
- 2003-07-25 DK DK03016945T patent/DK1500390T3/da active
- 2003-07-25 PT PT03016945T patent/PT1500390E/pt unknown
- 2003-07-25 ES ES03016945T patent/ES2243840T3/es not_active Expired - Lifetime
- 2003-07-25 EP EP03016945A patent/EP1500390B1/en not_active Revoked
2004
- 2004-07-19 BR BRPI0412905-9A patent/BRPI0412905A/pt not_active Application Discontinuation
- 2004-07-19 KR KR1020057006309A patent/KR20050104331A/ko not_active Ceased
- 2004-07-19 MX MXPA06000903A patent/MXPA06000903A/es active IP Right Grant
- 2004-07-19 AU AU2004260625A patent/AU2004260625B2/en not_active Ceased
- 2004-07-19 RU RU2005141230/15A patent/RU2303439C2/ru not_active IP Right Cessation
- 2004-07-19 CA CA002490335A patent/CA2490335C/en not_active Expired - Fee Related
- 2004-07-19 WO PCT/EP2004/051538 patent/WO2005011640A2/en active Application Filing
- 2004-07-19 NZ NZ544104A patent/NZ544104A/en not_active IP Right Cessation
- 2004-07-19 PL PL379704A patent/PL379704A1/pl not_active Application Discontinuation
- 2004-07-19 JP JP2006520833A patent/JP4430673B2/ja not_active Expired - Fee Related
- 2004-07-23 TW TW093122090A patent/TWI268782B/zh not_active IP Right Cessation
2005
- 2005-04-19 NO NO20051896A patent/NO327328B1/no not_active IP Right Cessation
2007
- 2007-11-22 IL IL187591A patent/IL187591A0/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP4430673B2 (ja)	2010-03-10
DE60301351D1 (de)	2005-09-22
MXPA06000903A (es)	2006-05-04
EP1500390B1 (en)	2005-08-17
NO327328B1 (no)	2009-06-08
RU2303439C2 (ru)	2007-07-27
KR20050104331A (ko)	2005-11-02
AU2004260625A1 (en)	2005-02-10
WO2005011640A2 (en)	2005-02-10
AU2004260625B2 (en)	2007-12-06
SI1500390T1 (sl)	2006-02-28
NO20051896L (no)	2005-04-19
WO2005011640A3 (en)	2005-03-24
CA2490335C (en)	2006-01-31
IL187591A0 (en)	2008-03-20
HK1072009A1 (en)	2005-08-12
NZ544104A (en)	2008-06-30
US7022340B2 (en)	2006-04-04
TW200509995A (en)	2005-03-16
BRPI0412905A (pt)	2006-09-26
ES2243840T3 (es)	2005-12-01
ATE301990T1 (de)	2005-09-15
EP1500390A1 (en)	2005-01-26
RU2005141230A (ru)	2006-07-10
TWI268782B (en)	2006-12-21
PL379704A1 (pl)	2006-11-13
CA2490335A1 (en)	2005-01-25
PT1500390E (pt)	2005-10-31
DE60301351T2 (de)	2006-01-19
US20050019392A1 (en)	2005-01-27
JP2007517762A (ja)	2007-07-05

Publication	Publication Date	Title
IL187591A0 (en)	2008-03-20	Pharmaceutical composition as solid dosage from and method for manufacturing thereof
TW200505406A (en)	2005-02-16	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
SG146608A1 (en)	2008-10-30	Rapid dissolution formulation of a calcium receptor-active compound
EA200700566A1 (ru)	2008-08-29	Фармацевтические композиции, включающие леветирацетам, и способы их получения
MY148773A (en)	2013-05-31	Galenic formulations of organic compounds
EA200401583A1 (ru)	2005-06-30	Таблетка лазофоксифена и ее покрытие
MY138734A (en)	2009-07-31	Casr antagonist
EA200301040A1 (ru)	2004-04-29	Способ производства фармацевтической композиции низкой дозы
WO2004078105A3 (fr)	2004-10-28	Composition de fondaparinux sodique de haute purete
TW200800984A (en)	2008-01-01	New compounds
ATE329581T1 (de)	2006-07-15	Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
TW200640465A (en)	2006-12-01	New pharmaceutically active compounds for the treatment of respiratory diseases
SE0102440D0 (sv)	2001-07-05	New compound
AR046226A1 (es)	2005-11-30	Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
TW200606164A (en)	2006-02-16	New compounds
GB0212410D0 (en)	2002-07-10	Organic compounds
WO2004048381A3 (en)	2004-08-05	Pyrazoloazepine compounds as pharmaceutical agents
DE60302951D1 (de)	2006-02-02	Pyroglutaminsäure-salz von Amlodipin
DK1473029T3 (da)	2005-04-18	Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
IL163025A (en)	2010-06-16	Prucalopride - n - oxides, their preparation and pharmaceutical compositions comprising them
EA200401082A1 (ru)	2005-04-28	Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
TW200518749A (en)	2005-06-16	Stabilised pharmaceutical compositions